miR-146a Attenuates Sepsis-Induced Myocardial Dysfunction by Suppressing IRAK1 and TRAF6 via Targeting ErbB4 Expression

Figure 6

ROS level detected by DHE assay. Overexpression of miR-146a significantly reduced the ROS level post-LPS treatment, and siErbB4 significantly reversed the effect.